IN2015MU03858A - - Google Patents

Info

Publication number
IN2015MU03858A
IN2015MU03858A IN3858MU2015A IN2015MU03858A IN 2015MU03858 A IN2015MU03858 A IN 2015MU03858A IN 3858MU2015 A IN3858MU2015 A IN 3858MU2015A IN 2015MU03858 A IN2015MU03858 A IN 2015MU03858A
Authority
IN
India
Prior art keywords
micafungin
sodium
formulation
micafungin sodium
disaccharide
Prior art date
Application number
Other languages
English (en)
Inventor
Mitesh Natavarlal PATEL
Mafatlal Tribhovandas Dave
Pranavkumar Jayesh CHOKSI
Original Assignee
Gufic Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of IN2015MU03858A publication Critical patent/IN2015MU03858A/en
Application filed by Gufic Biosciences Ltd filed Critical Gufic Biosciences Ltd
Priority to PCT/IN2016/050341 priority Critical patent/WO2017060923A1/en
Priority to IN3858MU2015 priority patent/IN2015MU03858A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
IN3858MU2015 2015-10-10 2016-10-07 IN2015MU03858A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2016/050341 WO2017060923A1 (en) 2015-10-10 2016-10-07 Freeze dried parenteral formulation of micafungin sodium and to process thereof
IN3858MU2015 IN2015MU03858A (zh) 2015-10-10 2016-10-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3858MU2015 IN2015MU03858A (zh) 2015-10-10 2016-10-07

Publications (1)

Publication Number Publication Date
IN2015MU03858A true IN2015MU03858A (zh) 2015-10-23

Family

ID=54398093

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3858MU2015 IN2015MU03858A (zh) 2015-10-10 2016-10-07

Country Status (2)

Country Link
IN (1) IN2015MU03858A (zh)
WO (1) WO2017060923A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3554474T3 (fi) * 2016-12-16 2024-02-21 Baxter Int Mikafungiinikoostumuksia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9561285B2 (en) * 2010-01-22 2017-02-07 Ascendis Pharma As Carrier-linked carbamate prodrug linkers
CN102614491B (zh) * 2011-01-31 2014-04-16 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途
CN103330933B (zh) * 2013-04-26 2015-08-05 江苏豪森药业股份有限公司 含有米卡芬净或其盐的药物组合物

Also Published As

Publication number Publication date
WO2017060923A1 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
PH12017500720A1 (en) Glycopeptide compositions
MY187047A (en) Selective pyy compounds and uses thereof
MX2018002627A (es) Metodo de cristalizacion y biodisponibilidad.
AU2015336400A8 (en) Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof
MX2016005395A (es) Formulacion estable de insulina glulisina.
MX2020007552A (es) Composicion farmaceutica estable que comprende esomeprazol y bicarbonato de sodio.
TW201613557A (en) Stable aqueous recombinant protein formulations
PH12017502376A1 (en) Oral solid formulation containing irinotecan and method of preparing the same
MX2016001422A (es) Composicion farmaceutica de fingolimod.
MX2017009289A (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
MX2019005775A (es) Formulacion farmaceutica parenteral que contiene acido carglumico.
HK1254855A1 (zh) 在手術期間給患者靜脈內施用瓜氨酸
GEP20237486B (en) Formulations of copanlisib
MX2017016774A (es) Agente terapeutico para la fibrosis.
PH12018501758A1 (en) Oritavancin formulations
IN2015MU03858A (zh)
GR1008234B (el) Παρεντερικο σκευασμα ενος αντιμυκητιασικου παραγοντα τριαζολης και μεθοδος για την παρασκευη αυτου
MX2017008072A (es) Formulaciones de un inhibidor de pi3k/mtor para administracion intravenosa.
MX2019008847A (es) Profarmacos de cisteamina.
IL253370A0 (en) Preparations containing hydroxy-cinnamic acid, conjugates, analogues, derivatives and methods of using them
PH12016502527B1 (en) Stabilized desmopressin
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
TR201721065A2 (tr) Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar
UA91650U (uk) Фармацевтична композиція похідних гамма-аміномасляної кислоти для твердих капсул